חזרה לתוצאות החיפוש

Study to Evaluate the Effectiveness and Safety of Ozanimod Compared to Fingolimod in Children and Adolescents With Relapsing Remitting Multiple Sclerosis

חו"ל (דורש נסיעה)מגייס משתתפיםPHASE3

מצבים רפואיים

Multiple Sclerosis, Relapsing-Remitting

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים

  • Local Institution - 0114, Loma Linda, California, United States

  • University of California Davis Health, Sacramento, California, United States

    Contact: Study coordinator (Frederick Bassal) · 916-734-3588

  • University of South Florida, Tampa, Florida, United States

    Contact: Study coordinator (Natalie Moreo) · 813-396-9478

  • Local Institution - 0093, Chicago, Illinois, United States

  • University of Chicago Medical Center, Chicago, Illinois, United States

    Contact: Study coordinator (Moon Hee Hur) · 773-702-6673

  • University of Louisville, Norton Children's Research Institute, Louisville, Kentucky, United States

    Contact: Study coordinator (Michael Sweeney) · 502-629-5606

  • Local Institution - 0131, New Brunswick, New Jersey, United States

  • Local Institution - 0132, Teaneck, New Jersey, United States

  • Local Institution - 0091, Cincinnati, Ohio, United States

  • Local Institution - 0092, Portland, Oregon, United States

  • Local Institution - 0133, El Paso, Texas, United States

  • Medical College of Wisconsin, Milwaukee, Wisconsin, United States

    Contact: Study coordinator (Ahmed Obeidat) · 414-955-0619

  • Royal Children's Hospital, Melbourne, Victoria, Australia

    Contact: Study coordinator (Eppie Yiu) · 6139455661

  • University of Naples Federico II, Naples, Campania, Italy

    Contact: Study coordinator (Vincenzo Brescia Morra) · +39081743741

  • Ospedale San Raffaele, Milan, Lombardy, Italy

    Contact: Study coordinator (Massimo Filippi) · +390226433958

  • Local Institution - 0081, Milan, Lombardy, Italy

  • Neurological Center Of Latium, Rome, Roma, Italy

    Contact: Study coordinator (Carlo Pozzilli) · 06.3377.5441

  • Local Institution - 0078, Mexico City, DIF, Mexico

  • Uniwersytecki Szpital Kliniczny w Poznaniu, Poznan, Greater Poland Voivodeship, Poland

    Contact: Study coordinator (Barbara Steinborn) · 48618691255

  • 2Ca Braga, Braga, Portugal

    Contact: Study coordinator (Joao Cerqueira) · +351915301556

  • Unidade Local de Saúde de Coimbra, E.P.E., Coimbra, Portugal

    Contact: Study coordinator (Filipe Palavra) · +351914632128

  • Centro Hospitalar de Lisboa Central, Lisbon, Portugal

    Contact: Study coordinator (João Sequeira) · 00351912576085

  • Local Institution - 0102, Porto, Portugal

  • Local Institution - 0134, Caguas, Puerto Rico

  • Spitalul Clinic de Copii Doctor Victor Gomoiu, Bucharest, Bucharest, Romania

    Contact: Study coordinator (Raluca Teleanu) · 0040722241042

  • Prof. Dr. Alexandru Obregia Psychiatry Hospital, Bucharest, Bucharest, Romania

    Contact: Study coordinator (Cristina Pomeran) · 0040770419542

  • Local Institution - 0096, Esplugues de Llobregat, Barcelona [Barcelona], Spain

  • CHUVI- Hospital Alvaro Cunqueiro, Vigo, Pontevedra [Pontevedra], Spain

    Contact: Study coordinator (Elena Rodriguez) · +34986217300

  • Hospital Universitario Virgen Macarena, Seville, Spain

    Contact: Study coordinator (SARA EICHAU MADUEÑO) · 0034955006627

  • Hospital Universitari i Politecnic La Fe, Valencia, Spain

    Contact: Study coordinator (Francisco Pérez-Miralles)

  • Hospital Universitario Miguel Servet, Zaragoza, Spain

    Contact: Study coordinator (Jesus Martin Martinez)

  • National Taiwan University Hospital, Taipei, Taiwan

    Contact: Study coordinator (Wang-Tso Lee) · 0972651495

  • Ondokuz Mayıs Universitesi, Samsun, Turkey (Türkiye)

    Contact: Study coordinator (murat terzi) · +905323156884
מובילי המחקר

  • Bristol-Myers Squibb

    Study Director

    Bristol-Myers Squibb

צפייה במקור ב־ClinicalTrials.gov(נפתח בחלון חדש)